Tumor buster - where will the CAR-T cell therapy ‘missile’ go?

Chimeric antigen receptor (CAR) T cell (CAR-T cell) therapy based on gene editing technology represents a significant breakthrough in personalized immunotherapy for human cancer. This strategy uses genetic modification to enable T cells to target tumor-specific antigens, attack specific cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Chunrun, Zhang, Hao, Cao, Hui, Tang, Lanhua, Mo, Haoyang, Liu, Fangkun, Zhang, Liyang, Yi, Zhenjie, Long, Lifu, Yan, Luzhe, Wang, Zeyu, Zhang, Nan, Luo, Peng, Zhang, Jian, Liu, Zaoqu, Ye, Weijie, Liu, Zhixiong, Cheng, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580202/
https://www.ncbi.nlm.nih.gov/pubmed/36261831
http://dx.doi.org/10.1186/s12943-022-01669-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580202/
https://www.ncbi.nlm.nih.gov/pubmed/36261831
http://dx.doi.org/10.1186/s12943-022-01669-8

Ejemplares similares